MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Legendre, P.
Right arrow Articles by Westbrook, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Legendre, P.
Right arrow Articles by Westbrook, G. L.

Ifenprodil blocks N-methyl-D-aspartate receptors by a two-component mechanism

P Legendre and GL Westbrook

Vollum Institute, Oregon Health Sciences University, Portland 97201.

The inhibition of N-methyl-D-aspartate (NMDA) receptor channels by the vasodilatory and anti-ischemic agent ifenprodil was examined on cultured rat hippocampal neurons. Whole-cell and single-channel patch recordings were used. Ifenprodil inhibition of NMDA currents could be separated into two components, with IC50 values of 0.75 and 161 microM. The high and low affinity components were both voltage independent but could be separated by their kinetics and dependence on extracellular calcium and glycine. The maximal inhibition of inward current by ifenprodil (approximately 90%) was equally divided between the two components in 0.3 mM extracellular calcium and 500 nM glycine. The low affinity action of ifenprodil had rapid kinetics and appeared to result from allosteric inhibition of the glycine modulatory site on the NMDA receptor. The macroscopic kinetics of the high affinity component were slow. The rate of onset was concentration dependent, and complete recovery required 1-2 min. Unlike open-channel blockers, ifenprodil block was not use dependent, and pre-exposure to ifenprodil also reduced subsequent NMDA responses. Low concentrations of ifenprodil were less effective after calcium-dependent inactivation of whole-cell currents, but the IC50 was unaffected, suggesting that calcium and ifenprodil act on a common set of channels. On outside-out membrane patches, ifenprodil reduced the frequency of channel opening without altering the single-channel conductance. Open time histograms of the large conductance events revealed two mean open times of approximately 2 and 8 msec, but only the duration of the long openings was decreased by ifenprodil. This effect was concentration dependent and revealed a blocking rate constant of 6 x 10(7) M-1sec-1. However, the proportion of current blocked by low concentrations of ifenprodil was larger in outside-out patches than in whole-cell recordings, suggesting that intracellular factors may influence ifenprodil efficacy. These results indicate that high affinity ifenprodil binding is extracellular and does not require agonist binding or channel opening. Because low concentrations of ifenprodil only partially inhibited the current and affected only the long openings, ifenprodil may promote a modal shift in channel gating.

Volume 40, Issue 2, pp. 289-298, 08/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Neurosci.Home page
C. Weitlauf, Y. Honse, Y. P. Auberson, M. Mishina, D. M. Lovinger, and D. G. Winder
Activation of NR2A-Containing NMDA Receptors Is Not Obligatory for NMDA Receptor-Dependent Long-Term Potentiation
J. Neurosci., September 14, 2005; 25(37): 8386 - 8390.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Martina, M.-E. B.-Turcotte, S. Halman, G. Tsai, M. Tiberi, J. T Coyle, and R. Bergeron
Reduced glycine transporter type 1 expression leads to major changes in glutamatergic neurotransmission of CA1 hippocampal neurones in mice
J. Physiol., March 15, 2005; 563(3): 777 - 793.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. Perin-Dureau, J. Rachline, J. Neyton, and P. Paoletti
Mapping the Binding Site of the Neuroprotectant Ifenprodil on NMDA Receptors
J. Neurosci., July 15, 2002; 22(14): 5955 - 5965.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. M. Rodrigues, G. E. Schafe, and J. E. LeDoux
Intra-Amygdala Blockade of the NR2B Subunit of the NMDA Receptor Disrupts the Acquisition But Not the Expression of Fear Conditioning
J. Neurosci., September 1, 2001; 21(17): 6889 - 6896.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
H. M. Ibrahim, A. J. Hogg Jr., D. J. Healy, V. Haroutunian, K. L. Davis, and J. H. Meador-Woodruff
Ionotropic Glutamate Receptor Binding and Subunit mRNA Expression in Thalamic Nuclei in Schizophrenia
Am J Psychiatry, November 1, 2000; 157(11): 1811 - 1823.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
L. Cathala, C. Misra, and S. Cull-Candy
Developmental Profile of the Changing Properties of NMDA Receptors at Cerebellar Mossy Fiber-Granule Cell Synapses
J. Neurosci., August 15, 2000; 20(16): 5899 - 5905.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. L. Berger and P. Rebernik
Zinc and Ifenprodil Allosterically Inhibit Two Separate Polyamine-Sensitive Sites at N-Methyl-D-Aspartate Receptor Complex
J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1584 - 1591.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
T. Masuko, K. Kashiwagi, T. Kuno, N. D. Nguyen, A. J. Pahk, J.-i. Fukuchi, K. Igarashi, and K. Williams
A Regulatory Domain (R1-R2) in the Amino Terminus of the N-Methyl-D-Aspartate Receptor: Effects of Spermine, Protons, and Ifenprodil, and Structural Similarity to Bacterial Leucine/Isoleucine/Valine Binding Protein
Mol. Pharmacol., June 1, 1999; 55(6): 957 - 969.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
K. R. Tovar and G. L. Westbrook
The Incorporation of NMDA Receptors with a Distinct Subunit Composition at Nascent Hippocampal Synapses In Vitro
J. Neurosci., May 15, 1999; 19(10): 4180 - 4188.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis
The Glutamate Receptor Ion Channels
Pharmacol. Rev., March 1, 1999; 51(1): 7 - 62.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. M. Khan, M. C. Curras, J. Dao, F. A. Jamal, C. A. Turkowski, R. K. Goel, E. R. Gillard, S. D. Wolfsohn, and B. G. Stanley
Lateral hypothalamic NMDA receptor subunits NR2A and/or NR2B mediate eating: immunochemical/behavioral evidence
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1999; 276(3): R880 - R891.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. C. Brimecombe, M. J. Gallagher, D. R. Lynch, and E. Aizenman
An NR2B Point Mutation Affecting Haloperidol and CP101,606 Sensitivity of Single Recombinant N-Methyl-D-Aspartate Receptors
J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 627 - 634.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
J. N. C. Kew, J. G. Richards, V. Mutel, and J. A. Kemp
Developmental Changes in NMDA Receptor Glycine Affinity and Ifenprodil Sensitivity Reveal Three Distinct Populations of NMDA Receptors in Individual Rat Cortical Neurons
J. Neurosci., March 15, 1998; 18(6): 1935 - 1943.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. C. Brimecombe, F. A. Boeckman, and E. Aizenman
Functional consequences of NR2 subunit composition in single recombinant N-methyl-D-aspartate receptors
PNAS, September 30, 1997; 94(20): 11019 - 11024.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. R. Whittemore, V. I. Ilyin, and R. M. Woodward
Antagonism of N-Methyl-D-Aspartate Receptors by sigma  Site Ligands: Potency, Subtype-Selectivity and Mechanisms of Inhibition
J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 326 - 338.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. J. Gallagher, H. Huang, D. B. Pritchett, and D. R. Lynch
Interactions between Ifenprodil and the NR2B Subunit of the N-Methyl-D-aspartate Receptor
J. Biol. Chem., April 19, 1996; 271(16): 9603 - 9611.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1991 by the American Society for Pharmacology and Experimental Therapeutics